EP3626258
Aðferðir og samsetningar til dreifingar á ídúrónat-2-súlfatasa í miðtaugakerfi
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
25.6.2011EP published:
4.8.2021EP application number:
19192679.9
EP translation filed:
21.10.2021Grant published:
15.11.2021EPO information:
European Patent Register
Max expiry date:
24.6.2031Expiry date:
24.6.2026
Title:
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE
Timeline
Today
25.6.2011EP application
4.8.2021EP Publication
21.10.2021Translation submitted
15.11.2021Registration published
24.6.2026Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka, JP
Inventor
Name:
ZHU, GaozhongAddress:
Weston, MA Massachusetts 02493, US
Name:
LOWE, KrisAddress:
Boston, MA Massachusetts 02120, US
Name:
SHAHROKH, ZahraAddress:
Weston, MA Massachusetts 02493, US
Name:
CHRISTIAN, JamesAddress:
Grafton, MA Massachusetts 01519, US
Name:
FAHRNER, RickAddress:
Boxford, MA Massachusetts 01921, US
Name:
PAN, JingAddress:
Boxborough, MA Massachusetts 01719, US
Name:
WRIGHT, Teresa, LeahAddress:
Lexington, MA Massachusetts 02142, US
Name:
CALIAS, PericlesAddress:
Melrose, MA Massachusetts 02176, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
35885710 PDate:
25.6.2010Country:
US
Number:
36078610 PDate:
1.7.2010Country:
US
Number:
38786210 PDate:
29.9.2010Country:
US
Number:
201161435710 PDate:
24.1.2011Country:
US
Number:
201161442115 PDate:
11.2.2011Country:
US
Number:
201161476210 PDate:
15.4.2011Country:
US
Number:
201161495268 PDate:
9.6.2011Country:
US
Classification
Categories:
A61K 38/47, A61P 25/00, A61P 25/28, A61K 9/19, A61K 38/46
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 18.5.2022
Expires: 24.6.2023
Payer: Patice ehf.
Number: 13
Paid: 24.5.2023
Expires: 24.6.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 23.5.2024
Expires: 24.6.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 16.6.2025
Expires: 24.6.2026
Payer: Árnason Faktor ehf.